IVVD Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$53M2023-12-31 → 2025-12-31
EPS$-0.302021-12-31 → 2025-12-31
Free Cash Flow$-58M2022-12-31 → 2025-12-31
Net margin-183.9%2024-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
IVVD
5Y avg
Peer Median
Verdict
P/E (TTM)
-2.75Y avg ≈-2.6
≈-2.6
·
·
P/S (TTM)
4.2
·
44.0
Undervalued
P/B (MRQ)
1.35Y avg ≈1.6
≈1.6
2.1
Undervalued
Price / FCF (TTM)
-2.25Y avg ≈-3.9
≈-3.9
·
·
Price / Cash Flow (TTM)
-2.25Y avg ≈-3.9
≈-3.9
·
·
Price / Tangible Book
1.05Y avg ≈1.6
≈1.6
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
IVVD
5Y avg
Peer Median
Verdict
Operating Margin (TTM)
-192.8%
·
-320.8%
In line
EBITDA Margin
-104.0%
·
-320.8%
In line
Net Profit Margin (TTM)
-183.9%
·
-692.5%
Top tier
ROA (TTM)
-69.7%5Y avg ≈-58.4%
≈-58.4%
-29.4%
Top tier
ROE (TTM)
-95.9%5Y avg ≈-105.5%
≈-105.5%
-47.7%
Top tier
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
IVVD
5Y avg
Peer Median
Verdict
Current Ratio (MRQ)
5.95Y avg ≈7.1
≈7.1
7.5
Low liquidity
Quick Ratio
7.05Y avg ≈4.0
≈4.0
5.5
In line
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
IVVD
5Y avg
Peer Median
Verdict
Revenue YoY
110.5%
·
·
·
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
IVVD
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-0.305Y avg ≈$-2.22
≈$-2.22
·
·
Revenue / Share
$0.31
·
·
·
Cash Flow / Share
$-0.345Y avg ≈$-1.35
≈$-1.35
·
·
Cash / Share
$0.805Y avg ≈$1.01
≈$1.01
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
IVVD
5Y avg
Peer Median
Verdict
Asset Turnover
0.3
·
0.1
Top tier
Receivables Turnover
4.3
·
·
·
Revenue / Employee
≈$437.9K
·
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
14
Avg Surprise-130.4%
Next ReportNov 04, 2026
Period
Report
EPS Actual
EPS Est
Surprise
June 30, 2026
Aug 13, 2026
$-0.14
$-0.11
-28.7%
March 31, 2026
May 14, 2026
$-0.13
$-0.07
-73.8%
Dec. 31, 2025
$-0.04
$-0.09
55.2%
Sept. 30, 2025
$-0.06
$-0.08
26.5%
June 30, 2025
$-0.12
$-0.02
-404.2%
March 31, 2025
$-0.14
$-0.03
-357.5%
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement13
Metric
Trend
2025
2024
2023
Revenue
$53M
$25M
$0
R&D Expense
$38M
$137M
$159M
SG&A Expense
$67M
$63M
$49M
Operating Expenses
$109M
$202M
$213M
Operating Income
$-56M
$-177M
$-213M
Other Non-op
$3M
$7M
$14M
Income Tax
$0
$0
$0
Net Income
$-52M
$-170M
$-199M
EPS (Basic)
$-0.30
$-1.43
$-1.81
EPS (Diluted)
$-0.30
$-1.43
$-1.81
Shares (Basic)
172,212,902
118,555,073
109,526,053
Shares (Diluted)
172,212,902
118,555,073
109,526,053
EBITDA
$-56M
$-177M
$-213M
Balance Sheet21
Metric
Trend
2025
2024
2023
Cash & Equivalents
$227M
$69M
$201M
Receivables
$14M
$11M
$0
Inventory
·
$26M
$0
Prepaid Expense
$7M
$20M
$24M
Other Current Assets
·
$4M
·
Current Assets
$247M
$101M
$225M
PP&E (Net)
$1M
$2M
$2M
Other Non-current Assets
$110.0K
$34.0K
$175.0K
Total Assets
$277M
$130M
$229M
Accounts Payable
$14M
$10M
$8M
Accrued Liabilities
$19M
$50M
$41M
Current Liabilities
$34M
$62M
$50M
Capital Leases
$1M
$0
$722.0K
Other Non-current Liabilities
·
$0
$700.0K
Total Liabilities
$35M
$62M
$52M
Common Stock
$28.0K
$12.0K
$11.0K
Retained Earnings
$-954M
$-902M
$-732M
AOCI
$-41.0K
$-5.0K
$-13.0K
Stockholders' Equity
$242M
$68M
$177M
Liabilities + Equity
$277M
$130M
$229M
Shares Outstanding
281,987,033
119,835,162
110,160,684
Cash Flow10
Metric
Trend
2025
2024
2023
Stock-based Comp
$12M
$20M
$19M
Operating Cash Flow
$-58M
$-170M
$-173M
CapEx
$155.0K
$140.0K
$615.0K
Investing Cash Flow
$-155.0K
$-140.0K
$281M
Stock Issued
$254.0K
$223.0K
$240.0K
Stock Repurchased
·
$0
$1.0K
Net Stock Activity
$254.0K
$223.0K
$239.0K
Financing Cash Flow
$216M
$39M
$1M
Net Change in Cash
$157M
$-131M
$109M
Free Cash Flow
$-58M
$-171M
$-174M
Profitability5
Metric
Trend
2025
2024
2023
Operating Margin
-104.0%
-696.8%
·
Net Margin
-98.2%
-669.4%
·
EBITDA Margin
-104.0%
-696.8%
·
ROA
-25.8%
-94.8%
-64.9%
ROE
-36.9%
-225.5%
-93.7%
Liquidity & Solvency2
Metric
Trend
2025
2024
2023
Current Ratio
7.2
1.6
4.5
Quick Ratio
7.0
1.3
4.0
Efficiency2
Metric
Trend
2025
2024
2023
Asset Turnover
0.3
0.1
·
Receivables Turnover
4.3
4.7
·
Per Share5
Metric
Trend
2025
2024
2023
Book Value / Share
$0.86
$0.56
$1.61
Revenue / Share
$0.31
$0.21
·
Cash Flow / Share
$-0.34
$-1.44
$-1.58
Cash / Share
$0.80
$0.58
$1.82
EPS (TTM)
$-0.30
$-1.43
$-1.81
Growth Rates1
Metric
Trend
2025
2024
2023
Revenue YoY
110.5%
·
·
Valuation (TTM)10
Metric
Trend
2025
2024
2023
Revenue TTM
$53M
$25M
$0
Net Income TTM
$-52M
$-170M
$-199M
Market Cap
$697M
$53M
$434M
P/E
-8.2
-0.3
-2.2
P/S
13.0
2.1
·
P/B
2.9
0.8
2.4
P / Tangible Book
2.9
0.8
2.4
P / Cash Flow
-12.0
-0.3
-2.5
P / FCF
-11.9
-0.3
-2.5
Earnings Yield
-12.2%
-322.8%
-45.9%
Income Statement13
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Revenue
$14M
$14M
$17M
$13M
$12M
$11M
$14M
$9M
$2M
$0
$0
$0
$0
R&D Expense
$29M
$31M
$10M
$8M
$10M
$11M
$18M
$58M
$30M
$31M
$62M
$26M
$44M
SG&A Expense
$29M
$25M
$19M
$15M
$17M
$17M
$14M
$13M
$21M
$15M
$15M
$13M
$10M
Operating Expenses
$60M
$57M
$30M
$24M
$27M
$28M
$33M
$72M
$52M
$46M
$77M
$43M
$54M
Operating Income
$-46M
$-43M
$-13M
$-11M
$-15M
$-17M
$-19M
$-62M
$-49M
$-46M
$-77M
$-43M
$-54M
Other Non-op
$1M
$2M
$1M
$553.0K
$400.0K
$633.0K
$786.0K
$2M
$2M
$3M
$3M
$4M
$4M
Income Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Income
$-44M
$-41M
$-11M
$-10M
$-15M
$-16M
$-18M
$-61M
$-47M
$-43M
$-74M
$-39M
$-50M
EPS (Basic)
$-0.14
$-0.13
$0.02
$-0.06
$-0.12
$-0.14
$-0.14
$-0.51
$-0.40
$-0.38
$-0.67
$-0.36
$-0.46
EPS (Diluted)
$-0.14
$-0.13
$0.02
$-0.06
$-0.12
$-0.14
$-0.14
$-0.51
$-0.40
$-0.38
$-0.67
$-0.36
$-0.46
Shares (Basic)
320,435,078
309,670,101
·
170,169,865
120,016,132
119,883,479
·
119,495,284
119,362,670
115,618,209
·
109,754,812
109,450,071
Shares (Diluted)
320,435,078
309,670,101
·
170,169,865
120,016,132
119,883,479
·
119,495,284
119,362,670
115,618,209
·
109,754,812
109,450,071
EBITDA
$-46M
$-43M
·
$-11M
$-15M
$-17M
·
$-62M
$-49M
$-46M
·
$-43M
$-54M
Balance Sheet21
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Cash & Equivalents
$160M
$184M
$227M
$85M
$35M
$48M
$69M
$107M
$148M
$189M
$201M
$182M
$122M
Receivables
$11M
$12M
$14M
$10M
$9M
$9M
$11M
$8M
$3M
·
$0
·
·
Inventory
·
·
·
$25M
$25M
$25M
·
$27M
$5M
$109.0K
$0
·
·
Prepaid Expense
$11M
$9M
$7M
$15M
$16M
$19M
$20M
$9M
$17M
$20M
$24M
$5M
$12M
Other Current Assets
·
·
·
·
$2M
·
·
·
·
·
·
·
·
Current Assets
$182M
$205M
$247M
$110M
$59M
$76M
$101M
$151M
$173M
$210M
$225M
$270M
$310M
PP&E (Net)
$2M
$2M
$1M
$1M
$1M
$2M
$2M
$2M
$2M
$2M
$2M
$2M
$2M
Other Non-current Assets
$1M
$1M
$110.0K
$6.0K
$15.0K
$24.0K
$34.0K
$7M
$2M
$2M
$175.0K
$187.0K
$291.0K
Total Assets
$219M
$242M
$277M
$139M
$89M
$104M
$130M
$162M
$177M
$215M
$229M
$275M
$315M
Accounts Payable
$9M
$2M
$14M
$18M
$18M
$9M
$10M
$18M
$7M
$1M
$8M
$9M
$4M
Accrued Liabilities
$20M
$28M
$19M
$25M
$25M
$40M
$50M
$59M
$27M
$34M
$41M
$16M
$27M
Current Liabilities
$31M
$32M
$34M
$44M
$44M
$50M
$62M
$79M
$37M
$36M
$50M
$27M
$33M
Capital Leases
$7M
$7M
$1M
$2M
$2M
$0
$0
$219.0K
$0
$625.0K
$722.0K
$927.0K
$1M
Other Non-current Liabilities
·
·
·
·
·
·
·
$0
$0
$0
$700.0K
$700.0K
·
Total Liabilities
$38M
$39M
$35M
$46M
$46M
$50M
$62M
$79M
$37M
$37M
$52M
$28M
$34M
Common Stock
$29.0K
$28.0K
$28.0K
$22.0K
$12.0K
$12.0K
$12.0K
$12.0K
$12.0K
$12.0K
$11.0K
$11.0K
$11.0K
Retained Earnings
$-1.04B
$-996M
$-954M
$-943M
$-933M
$-918M
$-902M
$-884M
$-823M
$-776M
$-732M
$-658M
$-619M
AOCI
$-35.0K
$-37.0K
$-41.0K
$-41.0K
$-39.0K
$-13.0K
$-5.0K
$-18.0K
$-12.0K
$-12.0K
$-13.0K
$-2.0K
$-22.0K
Stockholders' Equity
$181M
$203M
$242M
$93M
$43M
$54M
$68M
$83M
$141M
$178M
$177M
$246M
$282M
Liabilities + Equity
$219M
$242M
$277M
$139M
$89M
$104M
$130M
$162M
$177M
$215M
$229M
$275M
$315M
Shares Outstanding
294,755,090
282,803,863
281,987,033
214,409,450
120,142,811
119,961,445
119,835,162
119,604,035
119,442,635
119,221,230
110,160,684
109,846,329
109,570,333
Cash Flow10
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Stock-based Comp
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$8M
$5M
$4M
$4M
$5M
Operating Cash Flow
$-43M
$-42M
$-15M
$-8M
$-13M
$-21M
$-38M
$-41M
$-42M
$-50M
$-59M
$-35M
$-37M
CapEx
$510.0K
$726.0K
$0
$0
$11.0K
$144.0K
$-5.0K
$5.0K
$0
$140.0K
$0
$0
$-9.0K
Investing Cash Flow
$-510.0K
$-726.0K
$0
$0
$-11.0K
$-144.0K
$5.0K
$-5.0K
$0
$-140.0K
$78M
$95M
$33M
Stock Issued
$120.0K
$135.0K
$76.0K
$56.0K
$78.0K
$44.0K
$32.0K
$27.0K
$75.0K
$89.0K
$44.0K
$57.0K
$56.0K
Stock Repurchased
·
·
·
·
·
·
·
$0
·
·
$0
$0
$1.0K
Net Stock Activity
·
$135.0K
·
·
·
$44.0K
·
·
·
$89.0K
·
·
·
Financing Cash Flow
$19M
$-98.0K
$157M
$58M
$131.0K
$10.0K
$77.0K
$61.0K
$92.0K
$39M
$141.0K
$92.0K
$270.0K
Net Change in Cash
$-24M
$-43M
$142M
$50M
$-13M
$-21M
$-38M
$-41M
$-42M
$-11M
$19M
$60M
$-5M
Free Cash Flow
·
$-42M
·
·
·
$-21M
·
·
·
$-50M
·
·
·
Profitability5
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Operating Margin
-320.8%
-313.9%
·
-84.0%
-127.8%
-149.7%
·
-670.0%
-2175.2%
·
·
·
·
Net Margin
-310.8%
-301.2%
·
-79.8%
-124.4%
-144.1%
·
-653.1%
-2086.9%
·
·
·
·
EBITDA Margin
-320.8%
-313.9%
·
-84.0%
-127.8%
-149.7%
·
-670.0%
-2175.2%
·
·
·
·
ROA
-28.8%
-24.0%
·
-7.0%
-11.0%
-10.2%
·
-27.8%
-19.2%
-15.4%
·
-11.3%
-12.6%
ROE
-39.7%
-32.2%
·
-11.9%
-16.0%
-14.0%
·
-36.9%
-22.4%
-17.2%
·
-12.6%
-14.4%
Liquidity & Solvency2
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Current Ratio
5.9
6.5
·
2.5
1.3
1.5
·
1.9
4.7
5.8
·
10.1
9.5
Quick Ratio
5.5
6.2
·
2.1
1.0
1.1
·
1.5
4.1
5.2
·
6.8
3.8
Efficiency2
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Asset Turnover
0.1
0.1
·
0.1
0.1
0.1
·
0.0
0.0
·
·
·
·
Receivables Turnover
1.4
1.4
·
1.5
2.0
2.6
·
2.3
1.6
·
·
·
·
Per Share5
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Book Value / Share
$0.61
$0.72
·
$0.43
$0.36
$0.45
·
$0.70
$1.18
$1.50
·
$2.24
$2.57
Revenue / Share
$0.04
$0.04
·
$0.08
$0.10
$0.09
·
$0.08
$0.02
·
·
·
·
Cash Flow / Share
·
$-0.13
·
·
·
$-0.18
·
·
·
$-0.43
·
·
·
Cash / Share
$0.54
$0.65
·
$0.40
$0.29
$0.40
·
$0.89
$1.24
$1.59
·
$1.66
$1.11
EPS (TTM)
$-0.31
$-0.29
·
$-0.46
$-0.91
$-1.19
·
$-1.96
$-1.81
$-1.87
·
$-1.55
$-1.61
Valuation (TTM)9
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Revenue TTM
$58M
$56M
·
$50M
$46M
$37M
·
$12M
$2M
$0
·
·
·
Net Income TTM
$-107M
$-78M
·
$-60M
$-110M
$-143M
·
$-225M
$-204M
$-207M
·
$-170M
$-175M
Market Cap
$257M
$368M
·
$236M
$86M
$73M
·
$122M
$131M
$529M
·
$187M
$115M
P/E
-2.8
-4.5
·
-2.4
-0.8
-0.5
·
-0.5
-0.6
-2.4
·
-1.1
-0.7
P/S
4.4
6.6
·
4.7
1.9
2.0
·
10.5
58.0
·
·
·
·
P/B
1.4
1.8
·
2.5
2.0
1.3
·
1.5
0.9
3.0
·
0.8
0.4
P / Tangible Book
1.4
1.8
·
2.5
2.0
1.3
·
1.5
0.9
3.0
·
0.8
0.4
P / Cash Flow
·
-8.8
·
·
·
-3.4
·
·
·
-10.5
·
·
·
Earnings Yield
-35.5%
-22.3%
·
-41.8%
-127.3%
-196.7%
·
-192.2%
-164.5%
-42.1%
·
-91.2%
-153.3%
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Revenue
$53M
$25M
$0
·
·
Operating Margin %
-104.0%
-696.8%
·
·
·
Net Income
$-52M
$-170M
$-199M
$-241M
$-227M
Diluted EPS
$-0.30
$-1.43
$-1.81
$-2.23
$-5.32
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Current Ratio
7.2
1.6
4.5
15.1
·
Quick Ratio
7.0
1.3
4.0
3.7
·
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Free Cash Flow
$-58M
$-171M
$-174M
$-222M
·
Institutional owners (13F)
139 filers
· $257.2M total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders139
Value held$257.2M
New positions34
Exited positions43
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
34 (-9 vs prior Q)
43 (+29 vs prior Q)
41 (+3 vs prior Q)
28 (-2 vs prior Q)
-26.3M
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Population Health Equity Partners III, L.P., Population Health Equity Partners III GP, LLC, Population Health Equity Partners VII, L.P., Population Health Equity Partners VII GP, LLC, Clive Meanwell, Christopher Cox
×3 filings
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders
33 insiders
· 15 officers · 19 directors